William J. McGee’s Testimony at Senate Antitrust Subcommittee Hearing, “Examining Competition in America’s Skies”
September 30, 2025 — William J. McGee, Senior Fellow for Aviation and Travel at the American Economic Liberties Project, testifies in the Senate Judiciary Subcommittee on Antitrust, Competition Policy, and Consumer Rights for a hearing on "Examining Competition in America's Skies."
The Penny Price Pharmacy Toolkit: How Local Government Can Leverage the Federal 340B Program to Lower Out-of-Pocket Prescription Drug Costs
August 14, 2025 — This toolkit explains how local lawmakers can leverage an obscure federal drug-pricing program, called 340B, that allows safety-net health care providers — often publicly owned — to purchase prescription drugs at special low prices, including the underlying legal authority.
Taking On Power Buyers: Expedient, High-Impact Enforcement of Federal and California Price Discrimination Laws
July 25, 2025 — This document outlines potential expedient, high-impact paths for legal action by a disfavored retailer or retailer association against a favored buyer for certain forms of price discrimination under federal and California law.
Morgan’s Monopoly Digest – July 2025
July 23, 2025 — July version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.
Written Comments to the FTC in Response to Synopsys-Ansys Consent Decree
July 7, 2025 — Economic Liberties submitted a comment letter in response to the FTC's request for comments regarding the Consent Agreement proposed by the Commission to avoid filing a lawsuit to challenge an anticompetitive $35 billion merger between Synopsys, Inc. and ANSYS, Inc.
Morgan’s Monopoly Digest – June 2025
June 16, 2025 — June version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.